EKSO Stock UPDATES Ekso Bionics Holding (EKSO) 0.9900 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 10, 2014 at 9:47 PM

Ekso Bionics Holding (EKSO) 0.9900 $EKSO

Ekso Bionics(TM) to Demonstrate Robotic Exoskeleton Technology at Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo
GlobeNewswire - Fri Aug 29, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Ekso Bionics will be demonstrating their technology at the Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo August 31 thru September 3 at Hyatt Regency at the Arch, St. Louis Missouri. With close to 80 suits being used on over 60 centers internationally, Ekso Bionics is the most widely used robotic exoskeleton rehabilitation device worldwide.

Ekso Bionics(TM) to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 4:00PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern time at The InterContinental Hotel in Boston, MA. A live demonstration of their bionic exoskeleton technology will also be provided. Interested parties can access a live audio webcast on the Ekso Bionics website or by directly registering with Canaccord. An archived presentation will be available on the web site for 30 days.

Ekso Bionics Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:44PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter ended June 30, 2014, as well as recent highlights.

Ekso Bionics(TM) CEO Nathan Harding Interview on CNBC's Closing Bell Rescheduled
GlobeNewswire - Mon Aug 04, 12:23PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that, due to a breaking announcement from President Obama, CEO Nathan Harding's interview will be rescheduled to a later date.

Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Today, on CNBC'S Closing Bell
GlobeNewswire - Mon Aug 04, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.

Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Monday August 4th on CNBC's Closing Bell
GlobeNewswire - Fri Aug 01, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.

Ekso Bionics to Provide Corporate Update and Host Second Quarter Call on Thursday, August 7, 2014
GlobeNewswire - Thu Jul 31, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss quarterly results for its second quarter 2014 and provide a general business update on Thursday, August 7, 2014 at 4:30pm ET.

Ekso Bionics(TM) Named 'Leading Robotics Company' by Healthcare Robotics: 2014
GlobeNewswire - Thu Jul 24, 6:01AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was featured in Robotics Business Review Industry Special Report 'Healthcare Robotics: 2014' that describes medical robotic exoskeletons as "probably the most exciting segment of the entire medical robotics market right now."

Kessler Foundation Presents Data on Ekso(TM) at World Congress of Biomechanics
GlobeNewswire - Tue Jul 22, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Kessler Foundation, a global leader in rehabilitation research, has presented preliminary data at World Congress of Biomechanics held in Boston, MA, July 5-10, showing that spinal cord injury (SCI) motor incomplete and complete users were able to actively increase step swing time, stride length and hip extension after walking with an Ekso(TM) robotic exoskeleton. Most notably, muscle activation per gait cycle increased with training and became more similar to able-bodied walking.

Ekso Bionics(TM) Completes Training at Switzerland's Largest Rehabilitation Center
Thomson Reuters ONE - Tue Jul 15, 6:00AM CDT
RICHMOND, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that SPC Nottwil has finished training their team of physiotherapists with their Ekso GT(TM) robotic exoskeleton for neurorehabilitation and started to book patients to learn how to walk again. SPC Nottwil is the largest of Switzerland's four special clinics for para and tetraplegics; they consistently treat over 70% of all people with spinal paralysis in Switzerland and are fully occupied all year round. They have joined an esteemed group of European centers with an Ekso(TM) robotic exoskeleton including the top rated Insitut Guttman in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark, now part of Glostrup Hospital. Robotic exoskeletons have been gaining adoption in the neurorehabilitation community as a strong and growing body of evidence shows they are able to engage the principles of neuroplasticity for improved patient outcomes.

Emerging Market Companies and Investor Updates Provided by BrokerBank Securities, Inc.
PR Newswire - Thu Jun 26, 6:00AM CDT
NYBD Holding, Inc. (OTCBB: NYBD) has filed for a name change and it has been accepted. The company will now be trading under (AQUA), will be named Pleasant Kids, Inc. and the company is expecting the name and symbol change to take affect within the next few business days.

Ekso Bionics(TM) to Present at the 9th Annual JMP Securities Healthcare Conference
GlobeNewswire - Wed Jun 18, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder will present a corporate update at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 2:30 p.m. EDT in New York City. A live demonstration of their bionic exoskeleton technology will also be provided.

Ekso Bionics(TM) CEO Nathan Harding Interviewed Live Today on Fox Business Network's "Opening Bell with Maria Bartiromo"
GlobeNewswire - Fri Jun 13, 5:30AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Maria Bartiromo on Fox Business Network's Opening Bell with Maria Bartiromo. Any interested parties may tune in and listen live.

Ekso Bionics(TM) Announces Launch of Ekso(TM) Labs
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that co-founder Russ Angold was named president of the company's division focused on technology development and future applications, formally named Ekso Labs. Russ will oversee and build out the division that is responsible for developing intellectual property through engineering contracts and research grants from government organizations and industrial partners, including the Department of Defense (DOD). Ekso Bionics has a long history of engineering services work creating an important intellectual property portfolio dating back to the company's inception in 2005.

Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Wed Mar 26, 7:45AM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.

General Electric Signs $400 Million Algerian Agreement; Growlife and Vape Holdings Enter Joint Venture
ACCESSWIRE - Wed Mar 19, 11:30PM CDT
General Electric Company (NYSE: GE) - For an in-depth report on General Electric Company follow: www.BullTrends.com/stockquote/GE

Ekso Bionics(TM) Expands Executive Team
GlobeNewswire - Mon Mar 10, 5:58PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, announced today that Glenn Davis and Thomas Looby have joined the company to amplify its sales and marketing strategies. Davis brings over 20 years of sales experience with Siemens Healthcare and a comprehensive understanding of how to drive revenue within the Healthcare Sector in major and emerging markets while Looby adds his experience in systematically driving adoption of novel, high tech solutions to critical healthcare problems, most recently with Given Imaging. Both Davis and Looby have considerable experience in medical device market development and will work in tandem to build a robust business for Ekso Bionics.

3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
GlobeNewswire - Wed Feb 19, 5:33PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it recently debuted the first ever 3D printed hybrid exoskeleton robotic suit, in collaboration with 3D Systems (NYSE

DD), at a Singularity University event in Budapest. Designers from 3D Systems created personalized three-dimensional elements from multiple 3D scans taken of Ekso Ambassador, Amanda Boxtel.

RE2, Inc. Awarded Contract to Develop Exoskeleton Simulator
Marketwire - Wed Feb 19, 7:03AM CST
RE2, Inc. announced today that the company has been awarded a Phase I Small Business Innovation Research (SBIR) program with the U.S. Army to develop the Biomechanical Exoskeleton Simulator System, a software tool to assess the impact of load carriage and body-wearable robotic devices on musculoskeletal health and performance. RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics(TM) (OTCBB: EKSO) and neuromusculoskeletal simulation leader, Dr. Scott Delp, faculty at Stanford University.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CAE Boosts Fiscal 2027 Outlook; Transformation On Track

Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...

Ingram Micro Joins S&P SmallCap 600 Amid M&A Moves

Market Shufflin’ as Ingram Micro Steps In The constant ebb and flow of the stock market got right interesting with Ingram Micro Holding Corp. (NYSE: INGM) slated to crawl into the S&P SmallCap 600. This dance change-up is all thanks to Viatris Inc. (NASD: VTRS) looking to wrap up its acquisition of Pacira BioSciences (NASD: PCRX). With this deal sealing the fate of...

'Luz de las Naciones' Event: A Cultural Milestone

A Vibrant Showcase of Culture and Faith Grab your seatbelt, because when you hear about a cultural event lighting up the scene, especially one backed by The Church of Jesus Christ of Latter-day Saints, it means something's brewing. We're diving headfirst into 'Luz de las Naciones,' a celebration that's keeping its promise to highlight Latin America's zest and vibrant...

Elron Ventures Advances Dual-Use Tech Investment Plans

A Strategic Dance through Conferences Elron Ventures is gearing up for an action-packed November slate, aiming to flaunt its prowess in investment across burgeoning tech fields like Defense Tech, Deep Tech, Cybersecurity, and AI. Now, any seasoned investor knows these are the buzzy sectors that could just be the workhorses pulling the future market cart. But what makes...

GFL's Big Share Conversion: Impact and Implications

Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...

China's Double 11 Fest Rings in $264B in 2026

Shifting Gears at the 2026 Double 11 Festival You blinked, and another record was shattered. China's "Double 11" Shopping Festival, with its rhythmic frenzy and relentless countdowns, clocked a staggering RMB 1,776.4 billion this year—roughly US$264.4 billion. This ain't no ordinary sale, it's a financial juggernaut, folks. As these platforms duke it out for every yuan,...

DarioHealth Eyes Growth with Rising Revenue and Reduced Costs

Quarterly Earnings Reflect Strategic Forward Movement This quarter, DarioHealth (NASDAQ: DRIO) decided to crank up the volume on its long-haul strategy. They've managed a respectable 6% revenue increase over last year, clocking in at $5.3 million for the third quarter of 2026. It's a slight nudge up from the previous quarter too, where they sat at $5.2 million. Not...

Can BWIN, CCC, PCRX Deals Really Serve Shareholders?

Shareholder Stakes: Caught in Controversy Well, here we go again. These days, it seems like shareholder lawsuits are cropping up as regularly as sunrise. We've got Halper Sadeh LLC on a warpath, targeting potential legal missteps in the megadeals involving Baldwin Group (NASDAQ:BWIN), CCC Intelligent Solutions Holdings (NASDAQ:CCC), and Pacira BioSciences (NASDAQ:PCRX)....

Eli Radiopharma Clinches Big Series A, Eyes Milestones

Making Waves in Radiopharmaceuticals Some days, it's not just about the numbers—it’s about the shift in an entire field. Eli Radiopharma just closed a grand RMB 400 million Series A financing, paving a path that could redefine radiopharmaceuticals. Kinfolk over at Huagai Capital led the charge, teaming up with Bayland Capital and a throng of other backers. They’re...

BSR REIT's Q3 2026 Financials: Strategic Progress Made

BSR REIT Hits Strategic Milestones in Q3 Here's a bit of exciting news hitting us from BSR Real Estate Investment Trust. They've dropped their financial results for the third quarter of 2026. Packed with some solid gains, this quarter wasn't just about the numbers—it was about the moves they've been making underneath it all. So, let's break down what they're up to, and...